PAK BioSolutions
Burke, US · Founded 2019 · Delaware corporation · 19 employees on LinkedIn · 2 known investors
Find your way into PAK BioSolutions
Sign up to see every warm intro you have to PAK BioSolutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PAK BioSolutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PAK BioSolutions builds automated systems and single-use flow kits for end-to-end continuous purification of biopharmaceuticals, running four continuous purification stages simultaneously for a stated 4X productivity gain over batch methods. Its equipment and GMP consumables serve biopharmaceutical manufacturers for both laboratory and GMP production.
Founders & leadership
Investors · 2
How we know: Arboretum Ventures's portfolio page · the company's own site · funding news · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5M disclosed across 2 rounds · 2019–2024
▶$5MraisedJun 2024 · 2 investors · Other TechnologyRule 506(b)
- Joanna PezziniExecutive Officer, Director
- Daniel KidleDirector
- Kevin Hill-ByrneExecutive Officer, Director
- Charles PurtellDirector
- Offering amount
- $8.5M
- Amount sold
- $5M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$30KraisedJul 2019 · 3 investors · Other TechnologyRule 506(b)
- Pezzini JoannaExecutive Officer
- Kevin Hill-ByrneExecutive Officer
- Offering amount
- $300K
- Amount sold
- $30K
- Proceeds to insiders
- $30.2K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as PAK BioSolutions.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $325K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does PAK BioSolutions do?
- PAK BioSolutions builds automated systems and single-use flow kits for end-to-end continuous purification of biopharmaceuticals, running four continuous purification stages simultaneously for a stated 4X productivity gain over batch methods. Its equipment and GMP consumables serve biopharmaceutical manufacturers for both laboratory and GMP production.
- Who are PAK BioSolutions's investors?
- PAK BioSolutions's investors include Arboretum Ventures, BroadOak Capital Partners.
- How much funding has PAK BioSolutions raised?
- PAK BioSolutions has disclosed $5M raised across 2 rounds.
- Where is PAK BioSolutions headquartered?
- PAK BioSolutions is headquartered in Burke, US.




